Zobrazeno 1 - 10
of 27
pro vyhledávání: '"A A Siromolot"'
Publikováno v:
Biotechnologia Acta, Vol 17, Iss 2, Pp 70-73 (2024)
Aim: Because of its involvement in membrane properties, annexin A5 has a significant impact on membrane-dependent processes within hemostasis, including the initiation of the coagulation cascade, the activation of factor X and prothrombin, and the fu
Externí odkaz:
https://doaj.org/article/98abd5866c1540a590df73030e0cbdf3
Publikováno v:
Biotechnologia Acta, Vol 17, Iss 2, Pp 3-35 (2024)
Aim. To obtain bioactive recombinant human HB-EGF and investigate its proliferation capacity. Methods. The pET32(a)-HB-EGF cloning plasmid was extracted from E. coli DH10B cells and transformed into E. coli BL21 (DE3) Rosetta cells. The expression
Externí odkaz:
https://doaj.org/article/538040cbce77453e90c4b5ae1395087b
Publikováno v:
Biotechnologia Acta, Vol 17, Iss 2, Pp 64-66 (2024)
Recent studies have shown that cross reacting material (CRM197), a nontoxic variant of diphtheria toxin, may play an important role in treating cancers with poor prognoses. Doxorubicin-hydrochloride (DOX) is an antineoplastic prescription medicine fo
Externí odkaz:
https://doaj.org/article/0cb81c933a0e4ccd92b5c9e5255a0aeb
Autor:
Zhukova, Dariia, Katashynska, Daryna, Siromolot, Andrii, Romaniuk, Svitlana, Kolybo, Denys, Komisarenko, Serhiy
Publikováno v:
In Journal of Drug Delivery Science and Technology June 2024 96
Publikováno v:
Biotechnologia Acta. 2024, Vol. 17 Issue 2, p70-73. 4p.
Publikováno v:
Biotechnologia Acta, Vol 15, Iss 4, Pp 37-40 (2022)
Background. Better and high-potency vaccines against diphtheria are urgently needed to provide broader protection against diverse strains and subtypes. Identification of novel broadly neutralizing epitopes targeted by protective antibodies could aid
Externí odkaz:
https://doaj.org/article/3d5bd2f950524a2d89fbc653e170948c
Publikováno v:
Biotechnologia Acta. 2024, Vol. 17 Issue 2, p64-66. 3p.
Publikováno v:
Biotechnologia Acta. 2024, Vol. 17 Issue 2, p33-35. 3p.
Autor:
O. I. Krynina, S. I. Romaniuk, O. B. Gorbatiuk, O. H. Korchynskyi, А. V. Rebriiev, Ya. S. Kulyk, Ye. O. Kozadaieva, A. A. Siromolot, M. M. Guzyk, D. V. Kolybo, S. V. Komisarenko
Publikováno v:
The Ukrainian Biochemical Journal, Vol 93, Iss 6, Pp 31-45 (2021)
The quickly emerged global COVID-19 pandemic raised a desperate need in the development of protecting vaccines targeting this disease. Therefore, a generation of effective producers of recombinant SARS-CoV-2 proteins became an urgent task. Its resolv
Externí odkaz:
https://doaj.org/article/6b30f382aa014b2689592a1b55e4c557
Autor:
DRONKO, L. M., LUTSENKO, T. M., KOROTKEVYCH, N. V., VOVK, I. O., ZHUKOVA, D. A., ROMANIUK, S. I., SIROMOLOT, A. A., LABYNTSEV, A. J., KOLYBO, D. V.
Publikováno v:
Ukrainian Biochemical Journal; Sep/Oct2024, Vol. 96 Issue 5, p5-20, 16p